The oncogenic role of MRPS23 was first found in metastatic progression, with its upregulation identified in recurrent cervical carcinomas exhibiting lymph node metastasis and enhanced proliferative and invasive capacities24. This evidence concerns the gene MRPS23 and metastatic malignant neoplasm in the lymph nodes.